Mastopon-Treat (Progesterone)

Progesterone in Mastopon-Treat acts on the endocrine system to provide progestational support in several hormone‑related conditions.

• Menopause: alleviates vasomotor symptoms and helps maintain endometrial stability when combined with estrogen.
• Luteal phase support: supports the uterine lining in assisted reproductive cycles to improve implantation potential.
• Premenstrual syndrome: reduces mood swings, breast tenderness, and bloating associated with the luteal phase.

• Progesterone penetrates cell membranes and binds to intracellular progesterone receptors, forming a hormone‑receptor complex that translocates to the nucleus. This complex interacts with specific DNA response elements, modulating transcription of target genes involved in menstrual cycle regulation, endometrial development, and inhibition of estrogen‑driven proliferation. The net effect is a progestational response that balances estrogen activity and prepares tissues for potential pregnancy.

Topical progesterone may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Skin irritation at the application site: redness, itching or mild rash.
• Localized swelling: mild edema where the product is applied.
• Headache: transient mild headache reported by some users.
• Nausea: occasional mild nausea unrelated to systemic absorption.

Serious or Rare Side Effects

• Allergic reaction: hives, swelling of face, lips or throat requiring immediate medical attention.
• Thromboembolic events: rare clot formation especially in patients with pre‑existing risk factors.
• Hormone‑dependent tumor progression: potential acceleration of existing breast or endometrial cancers.

When using Mastopon-Treat, several precautions should be observed to ensure safety and product efficacy.

• Assess medical history: verify absence of active hormone‑dependent malignancies before initiating therapy.
• Monitor for clotting disorders: avoid use in patients with known thromboembolic disease.
• Evaluate pregnancy status: progesterone therapy is generally contraindicated during pregnancy unless specifically prescribed.
• Review concomitant medications: consider potential interactions with anticoagulants or hormonal agents.
• Follow application guidelines: apply a thin layer to clean, dry skin and avoid occlusion.
• Store below 25°C: keep in the original container, protect from moisture and light.

Progesterone can influence the activity of several drugs, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): progesterone may enhance anticoagulant effect, increasing bleeding risk.
• CYP3A4 inducers (e.g., rifampin, carbamazepine): may markedly reduce progesterone levels, compromising therapeutic effect.

Moderate Interactions (Monitor Closely)

• Hormonal contraceptives: concurrent use may alter cycle regulation; monitor for breakthrough bleeding.
• Antifungal azoles (e.g., ketoconazole): can increase progesterone concentrations, potentially leading to side effects.
• Antidepressants (SSRIs): may modestly affect hormone metabolism; observe for mood changes.